{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Miami&page=47&state=Florida", "query": { "state": "Florida", "city": "Miami", "page": 47 }, "page_size": 10 }, "pagination": { "page": 47, "page_size": 10, "total_count": 2578, "total_pages": 258, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Miami&page=48&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Miami&page=46&state=Florida&page_size=10" }, "source": "local", "last_synced_at": "2026-11-04T23:24:40.241Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06615050", "title": "A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Graft-versus-host Disease (GVHD)" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Methotrexate (MTX)", "type": "DRUG" }, { "name": "Mycophenolate mofetil (MMF)", "type": "DRUG" }, { "name": "Ruxolitinib (Rux)", "type": "DRUG" }, { "name": "Tacrolimus (Tac)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 572, "start_date": "2025-04-02", "completion_date": "2031-01-17", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-10-22T14:28:59.660Z", "location_count": 30, "location_summary": "Palo Alto, California • San Francisco, California • Miami, Florida + 23 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06615050" }, { "nct_id": "NCT05651932", "title": "A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma", "Myeloma", "Myeloma Multiple" ], "interventions": [ { "name": "Cohort A1 & A2: KTX-1001", "type": "DRUG" }, { "name": "Cohort B1 & B2: KTX-1001+Mezigdomide", "type": "DRUG" }, { "name": "Cohort C1 & C2: KTX-1001 + Carfilzomib (KYPROLIS®)", "type": "DRUG" }, { "name": "Cohort D: KTX-1001+ pomalidomide (Pomalyst, Imnovid)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "K36 Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2023-02-22", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-11-04T23:24:40.241Z", "location_count": 19, "location_summary": "San Francisco, California • Jacksonville, Florida • Miami, Florida + 15 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05651932" }, { "nct_id": "NCT05320198", "title": "Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Anemia", "Myelodysplastic Syndromes", "Myelofibrosis", "Myelofibrosis Due to and Following Polycythemia Vera", "Myelofibrosis; Anemia", "Post-essential Thrombocythemia Myelofibrosis", "Primary Myelofibrosis" ], "interventions": [ { "name": "DISC-0974", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Disc Medicine, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2022-06-06", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-10-22T21:20:46.078Z", "location_count": 31, "location_summary": "Gilbert, Arizona • Duarte, California • Irvine, California + 26 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05320198" }, { "nct_id": "NCT07473778", "title": "Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Cabotegravir (CAB)", "type": "DRUG" }, { "name": "Emtricitabine/tenofovir alafenamide (F/TAF)", "type": "DRUG" }, { "name": "Emtricitabine/tenofovir disoproxil fumarate (F/TDF)", "type": "DRUG" }, { "name": "Lenacapavir Injection", "type": "DRUG" }, { "name": "Lenacapavir Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3000, "start_date": "2026-03-17", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T14:45:25.066Z", "location_count": 44, "location_summary": "Birmingham, Alabama • Beverly Hills, California • Los Angeles, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07473778" }, { "nct_id": "NCT07296315", "title": "Confirmatory Clinical Study in Active Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "High-dose MH002", "type": "DRUG" }, { "name": "Low-dose MH002", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MRM Health NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 204, "start_date": "2026-04-03", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T14:28:49.138Z", "location_count": 6, "location_summary": "Miami, Florida • Orlando, Florida • Palmetto Bay, Florida + 3 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Fayetteville", "state": "North Carolina" }, { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07296315" }, { "nct_id": "NCT07286214", "title": "Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Polymyalgia Rheumatica" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Sarilumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 300, "start_date": "2026-05-12", "completion_date": "2029-07-16", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T12:22:41.506Z", "location_count": 47, "location_summary": "Avondale, Arizona • Phoenix, Arizona • Tucson, Arizona + 42 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07286214" }, { "nct_id": "NCT07214571", "title": "A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "S-337395", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 192, "start_date": "2025-12-11", "completion_date": "2026-12-30", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T18:32:02.278Z", "location_count": 37, "location_summary": "Los Angeles, California • Modesto, California • Toluca Lake, California + 23 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Modesto", "state": "California" }, { "city": "Toluca Lake", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Cutler Bay", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07214571" }, { "nct_id": "NCT07184944", "title": "A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Duvakitug", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 751, "start_date": "2026-01-22", "completion_date": "2034-03-20", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-11-04T19:24:20.401Z", "location_count": 34, "location_summary": "Colorado Springs, Colorado • Kissimmee, Florida • Miami, Florida + 26 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07184944" }, { "nct_id": "NCT07184931", "title": "An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Duvakitug", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 980, "start_date": "2025-10-01", "completion_date": "2029-05-14", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-11-03T18:12:50.198Z", "location_count": 127, "location_summary": "Peoria, Arizona • Scottsdale, Arizona • Tucson, Arizona + 107 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07184931" }, { "nct_id": "NCT07120503", "title": "Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "WIN378", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Windward Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 600, "start_date": "2025-07-24", "completion_date": "2028-11-23", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T16:59:51.131Z", "location_count": 21, "location_summary": "Los Angeles, California • San Jose, California • Melbourne, Florida + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "White Marsh", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07120503" } ] }